Poster abstracts
9. Clinical aspects

P197 Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test (CDT)
P198 Benign multiple sclerosis after 20?years follow-up: the good prognostic factors
P199 Diffusion tensor imaging in multiple sclerosis: correlations with clinical disability
P200 Fatigue is not associated with raised inflammatory markers in patients with multiple sclerosis
P201 Pregnancy and multiple sclerosis: further analysis of factors predictive of post-partum relapse
P202 Insight and dysexecutive difficulties in multiple sclerosis (MS): predicting neurorehabilitation outcome
P203 A clinical study of primary progressive multiple sclerosis
P204 The spectrum of disability and handicap in multiple sclerosis (MS)
P205 Cardiovascular autonomic dysregulation and fatigue in multiple sclerosis
P206 Melatonin levels, sleep-wake pattern and fatigue in multiple sclerosis patients: modulation by interferon-b treatment
P207 EDSS Changes in IVMP-treated attacks in clinical practice
P208 Brain specific proteins distinguish between pathogenic different subtypes of multiple sclerosis
P209 Interferon neutralizing antibodies reduce clinical and MRI efficiacy in MS patients treated with interferon b 1a (Rebif?) - Observations from the PRISMS 4?year extension study
P210 Diffusion-weighted imaging correlates of cognitive dysfunction in relapsing-remitting multiple sclerosis
P211 Anticardiolipin antibodies are not a useful screening tool in a non-selected large group of patients with multiple sclerosis
P212 Evaluation of pain in 363 multiple sclerosis patients: correlation with disease characteristics
P213 The predictive value of oligoclonal bands and MRI in patients with isolated demyelinating syndromes
P214 Assessing mobility using the SMS, a summary score formed by adding the RMI (rivermead mobility index) with an ordinal version of the 9HPT (9-Hole PEG test)
P215 Quality of life among MS patients in Austria: results of a nationwide survey
P216 Neutralizing antibodies do not alter the therapeutic benefits of IFN-beta 1a in MS within the first year of therapy
P217 Right frontal lesion load and right temporal atrophy are correlated with depression in patients with multiple sclerosis
P218 Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis. A clinical and MR study
P219 Comparison of the efficacy of two therapies in the flu-like symptoms induced by interferon b?1-a (Avonex?), at the weekly dose of 30mg IM, in patients with relapsing remitting multiple sclerosis
P220 Menstrually related fluctuations of symptoms in multiple sclerosis
P221 Natural history of multiple sclerosis in children: comparison of the data from Moscow and Vancouver
P222 A study of quality of life on Multiple Sclerosis in Val?ncia (Spain)
P223 "TEMA" program: clinical experience since the "TEMA" cooperation group was established
P224 Comparative evaluation of cognitive dysfunction between RR and SP-MS patients
P225 Central persistent hyperacusis in a MS?patient with a brainstem lesion
P226 Oligoclonal bands in the spanish population
P227 A quality of life (QoL) measure in Multiple Sclerosis women with urinary disorders
P228 Guy's neurological disability scale: relation to the expanded disability status scale
P229 Fatigue in multiple sclerosis. Evaluation and a new pharmacological approach
P230 Speech problems in early multiple sclerosis
P231 A study of the course of progression among different types of multiple sclerosis (MS)
P232 Executive and memory assessment in 56 MS?patients
P233 MRI evidence of wallerian degeneration of corticospinal tract after an acute white matter inflammatory lesion
P234 Possible association of cyclophosphamide and interferon-b for the treatment of rapidly transitional multiple sclerosis patients
P235 Changes of MSFC and EDSS during treatment of relapses with methylprednisolone in patients with multiple sclerosis
P236 Planar arm movements in cerebellar multiple sclerosis patients: impaired ability to account for inertia
P237 Acute myelopathy onset in multiple sclerosis a long term prospective study
P238 Volumes of brain and spinal cord atrophy and plaques correlated with neurological disability in primary progressive multiple sclerosis
P239 Development of a fatigue assessment diary in multiple sclerosis
P240 High frequency of psoriasis in relatives of an Italian MS population
P241 New approach to evaluation of clinical state in patients with multiple sclerosis
P242 Quality of life in MS patients: predictive variables
P243 MR spectroscopy and cognitive impairment in primary progressive multiple sclerosis
P244 Freezing/Frontal Lobe Gait Disorder in Multiple Sclerosis
P245 Unexpected discontinuation of interferon b 1b in SPMS patients
P246 T1-weighted hypointense images in Magnetic Resonance Image (MRI) as a marker of cognitive affectation in Multiple Sclerosis (MS)
P247 Dysphagia in multiple sclerosis
P248 Interferon treatment in patients with multiple sclerosis -?our first experience
P249 Current attitude to the indication and methodics of urological examination in multiple sclerosis patients
P250 Multiple sclerosis and Hashimoto's thyroiditis. Report of four cases
P251 Early cognitive impairment in multiple sclerosis
P252 Relationship between neuropsychological status, fatigue and quality of life in patients with mild multiple sclerosis: a controlled study about 40?patients
P253 Polyglandular autoimmune syndrome and demyelinating disease. A new association?
P254 Cranial nerve lesions and peripheral neuropathy -?Radiculopathy in early multiple sclerosis

CONGRES ECTRIMS
6 - 9 septembre 2000
Toulouse

Retour au sommaire
 Lectures
Orals
Posters
Recherche par nom d'auteur
MASSON EDITEUR